quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:21·363d
SECFiling
Aerovate Therapeutics Inc. logo

SEC Form 10-Q filed by Aerovate Therapeutics Inc.

AVTE· Aerovate Therapeutics Inc.
Health Care
Original source

Companies

  • AVTE
    Aerovate Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jun 18UpdateEvercore ISI$2.00
  • Jun 18UpdateTD Cowen-
  • Jun 18UpdateWells Fargo$2.00
  • Jun 17UpdateGuggenheim-
  • Jun 17UpdateBTIG Research-
  • Jun 17UpdateWedbush$3.00

Related

  • INSIDER357d
    SEC Form 4 filed by Director Fairmount Funds Management Llc
  • INSIDER357d
    SEC Form 4 filed by Director Lavelle Erin
  • INSIDER357d
    SEC Form 4 filed by Director Klein Lawrence Otto
  • INSIDER357d
    SEC Form 4 filed by Director Cain Christopher W.
  • INSIDER357d
    SEC Form 4 filed by Director Dobmeier Eric
  • INSIDER357d
    New insider Fairmount Funds Management Llc claimed ownership of 3,220,368 shares (SEC Form 3)
  • INSIDER357d
    SEC Form 3 filed by new insider Lavelle Erin
  • INSIDER357d
    New insider Klein Lawrence Otto claimed ownership of 86,215 shares (SEC Form 3)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022